Biotech · Private company · Buffalo, NY, US
Pop Biotechnologies, Inc
Track this companyFree. Adds Pop Biotechnologies, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- Liposome-displayed ApoB fragment for active immunotherapy against atherosclerosisFiscal year 2026 · $309.8KNIH RePORTER 1R41HL184798-01A1 · fetched Nov 12, 2026
- Mosaic Display of Multivalent Tau and A-Beta peptides on Immunogenic SNAP LiposomesFiscal year 2026 · $822.3KNIH RePORTER 5R42AG082620-04 · fetched Nov 12, 2026
- Advanced testing of a hexavalent adjuvanted influenza vaccine platform for dose sparing, multiplexing, and rapid deploymentFiscal year 2026 · $949KNIH RePORTER 5R44AI181479-03 · fetched Nov 12, 2026
- Mosaic Display of Multivalent Tau and A-Beta peptides on Immunogenic SNAP LiposomesFiscal year 2025 · $833.3KNIH RePORTER 2R42AG082620-03 · fetched Nov 12, 2026
- Liposome-displayed peptide vaccine against disseminated candidiasis by clinically-relevant Candida speciesFiscal year 2025 · $300KNIH RePORTER 5R41AI184019-02 · fetched Nov 12, 2026
- Advanced testing of a hexavalent adjuvanted influenza vaccine platform for dose sparing, multiplexing, and rapid deploymentFiscal year 2025 · $949.2KNIH RePORTER 5R44AI181479-02 · fetched Nov 12, 2026
- Liposome-displayed peptide vaccine against disseminated candidiasis by clinically-relevant Candida speciesFiscal year 2024 · $300KNIH RePORTER 1R41AI184019-01A1 · fetched Nov 12, 2026
- Advanced testing of a hexavalent adjuvanted influenza vaccine platform for dose sparing, multiplexing, and rapid deploymentFiscal year 2024 · $950.2KNIH RePORTER 1R44AI181479-01 · fetched Nov 12, 2026
- Clinical Translation of Interstitial Chemophototherapy with Light-Activated Nanoparticulate DoxorubicinFiscal year 2024 · $249.9KNIH RePORTER 1SB1CA288098-01 · fetched Nov 12, 2026
- Mosaic Display of Multivalent Tau and A-Beta peptides on Immunogenic SNAP LiposomesFiscal year 2024 · $247.7KNIH RePORTER 5R41AG082620-02 · fetched Nov 12, 2026